CN Mobile Logo


Colorectal Cancer

Colorectal Cancer

The use of a noninvasive colorectal cancer screening test called a multi-target stool DNA test (mt-sDNA) detected the disease in patients who had previously avoided more invasive screening procedures.

New data indicates that entrectinib has clinical activity in patients with a variety of cancers with gene alterations in NTRK1/2/3, ROS1, or ALK who had never been treated with targeted agents.

Clinicians now have a new tool to better identify colorectal cancer in its early and more treatable state.

Drinking coffee resulted in a more than 25% decreased risk for developing colorectal cancer, according to the results of a new study.

The combination use of sulindac and erlotinib significantly reduced the number of small intestine, or duodenal, polyps present in patients with familial adenomatous polyposis.

A large cohort study showed that the risk of colorectal cancer is increased following a diagnosis of prostate cancer, suggesting colorectal cancer screening should be considered following a prostate cancer diagnosis.

Regular use of aspirin has been linked with a small but significant reduction in the risk for overall cancer, and especially gastrointestinal cancers.


Subscribe to Colorectal Cancer on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.